S1 BIOPHARMA
S1 Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of sexual dysfunction in both women and men. The company’s development programs include first-in-class non-hormonal therapies designed to treat diminished sexual desire by restoring the natural balance of key neurotransmitters in the brain. The company’s lead product candidate, Lorexys, is currently positioned to advance to a Phase 2b clinical trial for the treatment of hypoactive sexual desire disorder (HSDD) in women. S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.
S1 BIOPHARMA
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.s1biopharma.com
Total Employee:
1+
Status:
Active
Contact:
201-839-0941
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Euro WordPress 6.0 Gravatar Profiles
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Shifa Biomedical
Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.
Stromatis Pharma
Stromatis Pharma is developing a secreted frizzle-related protein 2 (sFRP2) antagonist for reverting stromal stellate cells.
Stock Details
Official Site Inspections
http://www.s1biopharma.com
- Host name: 108.181.20.77
- IP address: 108.181.20.77
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
